GTDIX
Price
$39.86
Change
-$0.29 (-0.72%)
Updated
Nov 18 closing price
Net Assets
1.12B
VEMAX
Price
$44.73
Change
-$0.29 (-0.64%)
Updated
Nov 18 closing price
Net Assets
141.19B
Interact to see
Advertisement

GTDIX vs VEMAX

Header iconGTDIX vs VEMAX Comparison
Open Charts GTDIX vs VEMAXBanner chart's image
Invesco Emerging Markets ex-China R5
Price$39.86
Change-$0.29 (-0.72%)
VolumeN/A
Net Assets1.12B
Vanguard Emerging Mkts Stock Idx Adm
Price$44.73
Change-$0.29 (-0.64%)
VolumeN/A
Net Assets141.19B
GTDIX vs VEMAX Comparison Chart in %
View a ticker or compare two or three
VS
GTDIX vs. VEMAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTDIX is a Hold and VEMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 141B vs. GTDIX (1.12B). VEMAX pays higher dividends than GTDIX: VEMAX (2.75) vs GTDIX (1.19). GTDIX was incepted earlier than VEMAX: GTDIX (20 years) vs VEMAX (19 years). GTDIX (1.08) is less costly to investors than VEMAX (0.13). GTDIX is a more actively managed with annual turnover of: 20.00 vs. VEMAX (8.00). VEMAX has a lower initial minimum investment than GTDIX: VEMAX (3000) vs GTDIX (1000000). GTDIX (21.97) and VEMAX (21.68) have marching annual gain over last year. VEMAX return over 5 years is better than : 25.41 vs. GTDIX (0.44).
GTDIXVEMAXGTDIX / VEMAX
Total Expense Ratio1.080.13831%
Annual Report Gross Expense Ratio1.080.13831%
Fund Existence20 years19 years-
Gain YTD22.38323.11397%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRA1000000N/A-
Net Assets1.12B141B1%
Annual Yield % from dividends1.192.7543%
Returns for 1 year21.9721.68101%
Returns for 3 years37.2148.6676%
Returns for 5 years0.4425.412%
Returns for 10 years68.7281.4884%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SURG1.940.04
+2.11%
SurgePays
PYXS4.710.06
+1.29%
Pyxis Oncology
R166.031.58
+0.96%
Ryder System
ABBV233.87-0.13
-0.06%
ABBVIE
DXPE85.62-1.35
-1.55%
DXP Enterprises